|
|
Volumn 3, Issue 1, 2001, Pages 117-124
|
|
Clinical trials update: Highlights of the scientific sessions of the American Heart Association year 2000: Val HeFT, COPERNICUS, MERIT, CIBIS-II, BEST, AMIOVIRT, V-MAC, BREATHE, HEAT, MIRACL, FLORIDA, VIVA and the first human cardiac skeletal muscle myoblast transfer for heart failure
a
a
a
a
a
a
|
|
Author keywords
AMIOVIRT; Post infarction care; V MAC; Val HeFT
|
|
Indexed keywords
AMIODARONE;
ATORVASTATIN;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
BISOPROLOL;
BOSENTAN;
BUCINDOLOL;
CARVEDILOL;
DARUSENTAN;
DIGOXIN;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
DOBUTAMINE;
DOPAMINE;
ENDOTHELIN A RECEPTOR ANTAGONIST;
FLUINDOSTATIN;
GLYCERYL TRINITRATE;
HYPOCHOLESTEROLEMIC AGENT;
METOPROLOL;
NESIRITIDE;
PLACEBO;
PROSTACYCLIN;
RECOMBINANT VASCULOTROPIN;
SIMVASTATIN;
SPIRONOLACTONE;
TEZOSENTAN;
TIROFIBAN;
UNCLASSIFIED DRUG;
VALSARTAN;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
CHOLESTEROL BLOOD LEVEL;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DEFIBRILLATOR;
FEMALE;
GENE THERAPY;
HEART FAILURE;
HEART INFARCTION;
HEART TRANSPLANTATION;
HUMAN;
HYPOTENSION;
KIDNEY FAILURE;
MAJOR CLINICAL STUDY;
MALE;
MEDICAL SOCIETY;
MYOBLAST;
NONHUMAN;
PATIENT CARE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RISK FACTOR;
SURVIVAL RATE;
VASODILATATION;
VERTIGO;
ANIMALS;
CLINICAL TRIALS;
DEFIBRILLATORS, IMPLANTABLE;
GENE THERAPY;
HEART FAILURE, CONGESTIVE;
HUMANS;
MUSCLE, SKELETAL;
|
|
EID: 0035142810
PISSN: 13889842
EISSN: None
Source Type: Journal
DOI: 10.1016/S1388-9842(00)00145-8 Document Type: Article |
|
Times cited : (33)
|
|
References (24)
|
